Clinical Trials Directory

Trials / Completed

CompletedNCT05317286

LVEF Prediction During ACS Using AI Algorithm Applied on Coronary Angiogram Videos

Prospective Validation of a Deep Learning Algorithm for Prediction of the Left Ventricular Ejection Fraction From Coronary Angiogram Videos in Patients With Acute Coronary Syndrome

Status
Completed
Phase
Study type
Observational
Enrollment
240 (actual)
Sponsor
Montreal Heart Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Left ventricular ejection fraction (LVEF) is one of the strongest predictors of mortality and morbidity in patients with acute coronary syndrome (ACS). Transthoracic echocardiography (TTE) remains the gold standard for LVEF measurement. Currently, LVEF can be estimated at the time of the coronary angiogram but requires a ventriculography. This latter is performed at the price of an increased amount of contrast media injected and puts the patients at risk for mechanical complications, ventricular arrhythmia or atrio-ventricular blocks. Artificial intelligence (AI) has previously been shown to be an accurate method for determining LVEF using different data sources. Fur the purpose of this study, we aim at validating prospectively an AI algorithm, called CathEF, for the prediction of real-time LVEF (AI-LVEF) compared to TTE-LVEF and ventriculography in patients undergoing coronary angiogram for ACS.

Conditions

Timeline

Start date
2022-06-01
Primary completion
2023-12-31
Completion
2024-02-29
First posted
2022-04-07
Last updated
2024-03-12

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05317286. Inclusion in this directory is not an endorsement.

LVEF Prediction During ACS Using AI Algorithm Applied on Coronary Angiogram Videos (NCT05317286) · Clinical Trials Directory